Blood Cancer Awareness

September is Blood Cancer Awareness month. Every year, more than one million people in the world are newly diagnosed with blood cancers such as leukaemia, lymphoma, and myeloma1. However, many people remain unaware of these often incurable blood cancers, which can develop in individuals of any age, gender or race.

While the incidence of blood cancers continues to grow, ongoing research, accurate testing, and clinical trials are resulting in better outcomes and treatments for patients. Bio-Connect supports the clinicians, researchers, and laboratories contributing to improving the lives of the patients living with blood cancer or related blood disorders today.

Bio-Connect provides Invivoscribe’s comprehensive suite of in vitro diagnostics, used for the identification of gene rearrangements, translocations, and mutations that are highly indicative of hematologic malignancies. Learn more about the identification of clonality in lymphoid diseases, the stratification of acute myeloid leukemia, and the tracking of minimal residual disease by contacting our Sales Manager, Ing. Dew Doekharan.